Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study

A multicentre phase 2 trial (single-stage design) was undertaken to test the efficacy and toxicity of carboplatin (AUC 6 according to Calvert) plus paclitaxel (175 mg/m(2)3-h infusion) every 4 weeks in the first line treatment of patients affected by extensive small cell lung cancer. The primary end...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Gridelli, C, Manzione, L, Perrone, F, Veltri, E, Cioffi, R, Caprio, M Grazia, Frontini, L, Rossi, A, Barletta, E, Barzelloni, M L, Bilancia, D, Gallo, C
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2001
विषय:
Regular Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363602/
https://ncbi.nlm.nih.gov/pubmed/11139310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1541
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन